Imaging Amyloid and Tau in the Retina: Current Research and Future Directions
Authors:
- 3 February 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 43 (2) , 168-179
Abstract
Background: The retina is a key focus in the search for biomarkers of Alzheimer's disease (AD) because of its accessibility and shared development with the brain. The pathological hallmarks of AD, amyloid beta (Aβ), and hyperphosphorylated tau (pTau) have been identified in the retina, although histopathologic findings have been mixed. Several imaging-based approaches have been developed to detect retinal AD pathology in vivo. Here, we review the research related to imaging AD-related pathology in the retina and implications for future biomarker research. Evidence Acquisition: Electronic searches of published literature were conducted using PubMed and Google Scholar. Results: Curcumin fluorescence and hyperspectral imaging are both promising methods for detecting retinal Aβ, although both require validation in larger cohorts. Challenges remain in distinguishing curcumin-labeled Aβ from background fluorescence and standardization of dosing and quantification methods. Hyperspectral imaging is limited by confounding signals from other retinal features and variability in reflectance spectra between individuals. To date, evidence of tau aggregation in the retina is limited to histopathologic studies. New avenues of research are on the horizon, including near-infrared fluorescence imaging, novel Aβ labeling techniques, and small molecule retinal tau tracers. Artificial intelligence (AI) approaches, including machine learning models and deep learning-based image analysis, are active areas of investigation. Conclusions: Although the histopathological evidence seems promising, methods for imaging retinal Aβ require further validation, and in vivo imaging of retinal tau remains elusive. AI approaches may hold the greatest promise for the discovery of a characteristic retinal imaging profile of AD. Elucidating the role of Aβ and pTau in the retina will provide key insights into the complex processes involved in aging and in neurodegenerative disease.Keywords
This publication has 56 references indexed in Scilit:
- Melanopsin retinal ganglion cell loss in Alzheimer diseaseAnnals of Neurology, 2015
- Hyperspectral Imaging Signatures Detect Amyloidopathy in Alzheimer’s Mouse Retina Well before Onset of Cognitive DeclineACS Chemical Neuroscience, 2014
- Microvascular network alterations in the retina of patients with Alzheimer's diseaseAlzheimer's & Dementia, 2014
- Beta‐Amyloid, Phospho‐Tau and Alpha‐Synuclein Deposits Similar to Those in the Brain Are Not Identified in the Eyes of Alzheimer's and Parkinson's Disease PatientsBrain Pathology, 2013
- Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic MicePLOS ONE, 2012
- Review: Tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain?2012
- Alzheimer’s Disease: The Challenge of the Second CenturyScience Translational Medicine, 2011
- Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse modelNeuroImage, 2011
- Age-related changes in the transmission properties of the human lens and their relevance to circadian entrainmentJournal of Cataract & Refractive Surgery, 2010
- Retinal ganglion cell degeneration in Alzheimer's diseaseBrain Research, 1989